InnoCan Pharma Corporation announced the addition of Dr. Kenji Kitatani, to Innocan pharma's Advisory Committee, as an advisor to the Asian markets. Dr. Kenji Kitatani is a leading global media and entertainment business expert with substantial corporate experience and academic expertise.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.285 CAD | 0.00% | -5.00% | -8.06% |
1st Jan change | Capi. | |
---|---|---|
-8.06% | 58.51M | |
+27.92% | 672B | |
+26.74% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+7.26% | 217B | |
+5.87% | 199B | |
-8.26% | 204B | |
-8.58% | 149B |
- Stock Market
- Equities
- INNO Stock
- News InnoCan Pharma Corporation
- Innocan Pharma Corporation Announces Appointment of Dr. Kenji Kitatani to Advisory Committee